Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 31, Number 1—January 2025
Dispatch

Fatal Case of Crimean-Congo Hemorrhagic Fever, Portugal, 2024

Líbia Zé-Zé1Comments to Author , Cristina Nunes1, Micaela Sousa, Rita de Sousa, Carla Gomes, Ana S. Santos, Rui T. Alexandre, Fátima Amaro, Tiago Loza, Miriam Blanco, and Maria J. Alves
Author affiliation: National Institute of Health Doutor Ricardo Jorge, Águas de Moura, Portugal (L. Zé-Zé, R. de Sousa, A.S. Santos, F. Amaro, M.J. Alves); Center for the Study of Animal Science, Porto, Portugal (L. Zé-Zé, F. Amaro, M.J. Alves); Northeastern Local Health Unit, Bragança, Portugal (C. Nunes, M. Sousa, C. Gomes, R.T. Alexandre, T. Loza, M. Blanco); Environmental Health Institute, Lisboa, Portugal (A.S. Santos, F. Amaro, M.J. Alves)

Main Article

Table 2

Laboratory data for patient in fatal case of Crimean-Congo hemorrhagic fever, Portugal, 2024*

Category (reference limit range)
D2
D6
D7
D8
D9
D10
D11
Hemoglobin, g/dL (14.0–17.5)
12.9
11.6
10.5
11.6
10.6
9.4
8.8
Leukocytes, 109 cells/L (4.4–11.3)
7.83
5.95
4.50
4.83
3.64
2.94
2.36
Neutrophils, 109 cells/L
7.44
4.22
3.11
3.10
2.82
2.29
1.82
Lymphocytes, 109 cells/L
0.24
1.49
1.22
1.56
0.71
0.57
0.50
Platelet count, 109/L (150–450)
156
6
5
7
13
14
10
C-reactive protein, mg/dL
0.15
3.44
1.95
1.57
0.75
0.66
1.03
Prothrombin time, s (9.4–12.5)
11.5
11.2
11
10.9
12.7
14.1
15.1
Activated partial thromboplastin time, s (25.1–36.5)
23.6
53.9
52.7
56.6
48.0
44.3
47.7
Fibrinogen, mg/dL
275
NT
NT
125
135
129
NT
Aspartate aminotransferase, IU/L (<35)
31
545
549
1,259
7,547
7,644
8,330
Alanine aminotransferase,e IU/L (<45)
19
141
149
370
2,272
2,471
2,659
Total bilirubin, mg/dL (0.3–1.2)
NT
0.81
0.93
1.49
2.57
3.92
5.34
Creatine kinase, IU/L (<171)
NT
372
NT
263
262
246
397
Lactate dehydrogenase, IU/L (<248)
285
2,278
1,879
2,495
8,655
9,712
10,980
Urine cultures
NT
Neg
NT
Neg
NT
NT
NT
Blood cultures Neg Neg NT Neg NT NT NT

*CCHFV, Crimean-Congo hemorrhagic fever virus; D, day after symptom onset; Neg, negative; NT, not tested; Pos, positive.

Main Article

1These first authors contributed equally to this article.

Page created: November 15, 2024
Page updated: December 22, 2024
Page reviewed: December 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external